Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck
- 1 September 2003
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (9) , 1141-1146
- https://doi.org/10.1001/archderm.139.9.1141
Abstract
Objective To determine the ability of fluorodeoxyglucose F 18 positron emission tomography (FDG-PET) to image basal cell carcinoma (BCC). Design Case series study. Setting Mohs surgery practice in a tertiary university hospital. Patients Six patients with BCC larger than 1.0 cm of the head and neck region were identified. Results Patients were imaged using FDG-PET before surgery. In 3 patients, PET imaging correlated well with the size and extent of the soft tissue invasion. Histologically, all 3 tumors were of the nodular subtype. The remaining 3 patients failed to demonstrate identifiable tumor activity on PET. Two of these 3 tumors were of the infiltrative histologic subtype, and 1 was of the nodular subtype. Perineural spread was detected by tissue biopsy in 1 infiltrative tumor, but not by FDG-PET imaging. Conclusions In our study, FDG-PET imaging was able to image and identify BCC in the head and neck region in 3 of 6 patients. In some cases, anatomic accuracy and the extent of soft tissue invasion were observed. The histologic subtype of the BCC appears to affect the ability of FDG-PET detection, with the nodular histologic subtype more likely to test positive on PET. This is a preliminary study, and future investigation is needed to evaluate the role of PET imaging in the management of patients with BCC.Keywords
This publication has 34 references indexed in Scilit:
- Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.Archives of Surgery, 1999
- Cost-effectiveness of FDG-PET for staging non–small cell lung cancer: a decision analysisThe Annals of Thoracic Surgery, 1998
- Detection of extrathoracic metastases by positron emission tomography in lung cancerThe Annals of Thoracic Surgery, 1998
- Whole-Body [ 18 F]FDG PET in the Management of Metastatic Brain TumoursActa Neurochirurgica, 1998
- Utility of FDG-PET for Investigating Unexplained Plasma CEA Elevation in Patients With Colorectal CancerAnnals of Surgery, 1998
- Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.Radiology, 1998
- Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.Radiology, 1997
- Positron Emission Tomography in the Pretreatment Evaluation and Follow-Up of Non-Small Cell Lung Cancer Patients Treated with Radiotherapy: Preliminary FindingsAmerican Journal of Clinical Oncology, 1996
- Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomographyThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.American Journal of Respiratory and Critical Care Medicine, 1996